Anthos Capital

Asset Manager SEC-registered adviser

Legal name: Anthos Management, L.P.

Santa Monica, CA Website X

AUM

$3.0B
Regulatory AUM

Private funds

9
Venture Capital 7 · Private Equity 2

Private fund assets

$1.4B
Gross asset value

Employees

30

Last Form D raise

Apr 2021
Most recent fund filing

From SEC Form ADV filing (filed Mar 30, 2026). View on SEC

People(4)

Owners and executive officers named on the firm's SEC Form ADV.

B
Member, Anthos Management GP
E
Partner, Singingwood Investment Partners
P
Member, Anthos Management GP
T
Member, Healey Development

Funds(9)

Private funds reported on Form ADV, with amounts raised from the funds' SEC Form D filings.

FundTypeGross assetsRaised (Form D)InvestorsLast Form DRecency
Anthos Capital V LPPrivate Equity$177.7M——Apr 2021Cold
Anthos Capital IV Co-Invest, L.P.Venture Capital$214.9M——May 2019Cold
Anthos Capital IV, L.P.Private Equity$493.3M——May 2019Cold
Acd Investors, L.P.Venture Capital$23.3M$30.5M9Jan 2019Cold
Anthos Capital III, L.P.Venture Capital$262.8M——Apr 2015Cold
Anthos Capital II Gb Series Aiv LPVenture Capital$145.5M———
Acd Holdings, L.P.Venture Capital$33.9M———
Anthos Capital II, L.P.Venture Capital$30.9M———
Anthos Tribe, L.P.Venture Capital$6.2M———

Board seats(1)

Companies whose SEC Form D filings name one of this firm's people as a director, matched by name and office ZIP code.

Cambrian BioPharma
BiotechnologyNew York, NYDirector: Paul Farr
$272.2M raised
Since Jan 2025
SEC Form D

Shares boards with

Firms whose people sit on the same company boards.

Regulatory identifiers

CRD number
165980
SEC file number
801-118356

Sources